Reports Q4 revenue $29.2M, consensus $36.66M. “The significant progress we made last year in advancing our immunology pipeline positions us for

Reports Q4 revenue $342M vs. $421.3M last year. “We are pleased to conclude the year with better than expected fourth quarter results, delivering

The headline numbers for Nektar (NKTR) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Reports Q4 revenue $497.92M vs. $466.91M last year. “We’re proud to report record revenue this year, with particularly strong results in our

Reports Q4 revenue $100.9M vs $108.1M last year. Commenting on the year, Ampco-Pittsburgh’s (AP) CEO, Brett McBrayer, said, “Our 2024 non-GAAP